In silico pharmacokinetic analysis of Morinda citrifolia phytochemicals and their potential antagonistic effect on prostatic carcinoma proteins
DYSONA – Life Science · 01.10.2022 · 3 (2) · 83
DOI: 10.30493/dls.2022.351879 ↗Kurz gefasst
Fachartikel in der Zeitschrift DYSONA – Life Science, online erschienen am 01.10.2022. Verfasst von Pratiksha Patil und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate carcinoma (PCA) is amongst the most prevalent types of cancer and the underlying cause of death in males across the globe. Despite various restorative advancements, cancer remains an incurable disease. Recent research has emphasised the chemo-preventive effects of phytonutrients and their ability to prevent malignancy. This study aims to identify the potential antagonistic affinity of phytochemicals present in M. citrifolia L. against PCA. Six inhibitory phytochemicals were analysed against human androgen receptors (PDB: 3RLJ, 5T8J, 5VO4) and prostate-specific antigens (PDB: 2ZCH, 2ZCK, 2ZCL). The ADME/T properties of the selected ligands were analysed using in silico methods (SwissADME). The ligands' affinity for a targeted protein was predicted by utilising online molecular-docking tools—Swiss Dock and UCSF Chimera. The in silico research results reported that among the 6 small molecules, Oleic acid showed a high-affinity LBD with PSA enzymes with active site chain A (auth P) (2ZCK: -8.41kJ/mol, 2ZCL: -8.27 kJ/mol) whereas, Alizarin, Lauric acid, and Morindone showed high-affinity LBD with AR active site chain A; PDB codes 3RLJ with ΔG values (-7.92kJ/mol, -7.95kJ/mol, and -7.90kJ/mol) respectively. This data hints that researchers can probably conduct further studies with this ADME/T rule and validate a potent molecule through other screening tests and clinical trials.
Zitieren
APA
Patil, P., & Shah, N. (2022). In silico pharmacokinetic analysis of Morinda citrifolia phytochemicals and their potential antagonistic effect on prostatic carcinoma proteins. DYSONA – Life Science, 3(2), 83. https://doi.org/10.30493/dls.2022.351879
Vancouver
Patil P, Shah N. In silico pharmacokinetic analysis of Morinda citrifolia phytochemicals and their potential antagonistic effect on prostatic carcinoma proteins. DYSONA – Life Science. 2022;3(2):83. doi:10.30493/dls.2022.351879
BibTeX
@article{Patil2022,
author = {Patil, Pratiksha and Shah, Nisha},
title = {In silico pharmacokinetic analysis of Morinda citrifolia phytochemicals and their potential antagonistic effect on prostatic carcinoma proteins},
journal = {DYSONA – Life Science},
year = {2022},
volume = {3},
number = {2},
pages = {83},
doi = {10.30493/dls.2022.351879}
}
EUVIMED